It is our pleasure to welcome you to the joint IIS-ISCR Special Conference - The Cutting Edge of Immunology, Cancer and Immunoncology Research, to be held on September 23-25, 2019 in Tel Aviv. Hosted by the Israel Immunological Society (IIS) the Israel Society for Cancer Research (ISCR.
The scientific spectrum will cover a wide collection of topics in contemporary immunology and cancer research ranging from basic principles to translational breakthroughs. Together with our colleagues in the organizing committee we assembled an excellent list of world-class speakers that will discuss key areas in innate and acquired immunity, immune-oncology and clinical cancer therapy. Special sessions will focus on research hot spots including lymphocyte activation and exhaustion, checkpoint inhibitors, Immunotherapy, Inflammation and immunity, and mechanotransduction in the Immune System, featuring both basic and translational investigators.
The conference format is designed to bring together basic, translational and clinical researchers, as well as researchers working on the development of new targeted therapeutics. Leading experts will present the latest achievements of multidisciplinary research dealing with drug action and resistance and highlight challenges that require a concerted multidisciplinary effort. The program will comprise Keynote Lectures, Plenary Symposia and parallel Scientific Symposia, and will include many slots for selected talks and poster presentations with ample time for questions and discussion.
We trust you will share our excitement about the exceptional scientific content and venue. We cordially invite you to this unique conference and look forward to greeting you in Tel Aviv.
Please see this as a personal invitation to join the immunology and cancer communities in celebrating the achievements of immunologists, cancer researchers and oncologists.
Mira Barda-Saad Angel Porgador
Conference Co-Chair IIS Conference Co-Chair ISCR